HK1206983A1 - Orally disintegrating tablet and method for producing same - Google Patents
Orally disintegrating tablet and method for producing sameInfo
- Publication number
- HK1206983A1 HK1206983A1 HK15107618.0A HK15107618A HK1206983A1 HK 1206983 A1 HK1206983 A1 HK 1206983A1 HK 15107618 A HK15107618 A HK 15107618A HK 1206983 A1 HK1206983 A1 HK 1206983A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- orally disintegrating
- disintegrating tablet
- producing same
- tablet
- orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012098770 | 2012-04-24 | ||
| PCT/JP2013/061936 WO2013161823A1 (ja) | 2012-04-24 | 2013-04-23 | 口腔内崩壊錠及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1206983A1 true HK1206983A1 (en) | 2016-01-22 |
Family
ID=49483132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15107618.0A HK1206983A1 (en) | 2012-04-24 | 2015-08-07 | Orally disintegrating tablet and method for producing same |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9827200B2 (xx) |
| EP (1) | EP2842549B1 (xx) |
| JP (4) | JP6066351B2 (xx) |
| KR (1) | KR101943686B1 (xx) |
| CN (2) | CN106913553A (xx) |
| BR (1) | BR112014026292B1 (xx) |
| CA (1) | CA2870868C (xx) |
| ES (1) | ES2694224T3 (xx) |
| HK (1) | HK1206983A1 (xx) |
| IN (1) | IN2014MN02029A (xx) |
| TW (1) | TWI572371B (xx) |
| WO (1) | WO2013161823A1 (xx) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3200772T3 (pl) * | 2014-10-03 | 2022-12-19 | Novartis Ag | Kompozycje farmaceutyczne zawierające alpelisyb |
| JP5827428B1 (ja) * | 2015-01-15 | 2015-12-02 | 日新製薬株式会社 | テルミサルタン含有錠剤 |
| JP2016141630A (ja) * | 2015-01-30 | 2016-08-08 | 富士フイルム株式会社 | 口腔内崩壊錠 |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| CN108066304B (zh) * | 2016-11-16 | 2022-09-16 | 深圳万和制药有限公司 | 具有缓释性能的坦索罗辛口腔崩解片组合物 |
| TWI812602B (zh) * | 2016-12-01 | 2023-08-21 | 日商第一三共股份有限公司 | 含二胺衍生物之口腔崩散錠及其製造方法 |
| JP7009288B2 (ja) * | 2017-05-18 | 2022-01-25 | エルメッド株式会社 | 湿製錠剤の製造方法及び湿製錠剤の品質向上方法 |
| JP7023186B2 (ja) * | 2017-05-29 | 2022-02-21 | 第一三共株式会社 | 認知症治療薬を含有する口腔内崩壊性錠剤 |
| JP7182356B2 (ja) * | 2017-07-05 | 2022-12-02 | 日本ケミファ株式会社 | 口腔内崩壊錠及びその製造方法 |
| JP7198575B2 (ja) * | 2017-07-11 | 2023-01-04 | キョーリンリメディオ株式会社 | メマンチン塩酸塩含有口腔内崩壊錠 |
| JP7148319B2 (ja) * | 2017-08-17 | 2022-10-05 | 第一三共株式会社 | プラスグレルを含む口腔内崩壊錠 |
| JP7360949B2 (ja) * | 2017-12-26 | 2023-10-13 | 東和薬品株式会社 | 環状口腔内崩壊錠 |
| JP7138666B2 (ja) * | 2018-01-24 | 2022-09-16 | 大原薬品工業株式会社 | γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
| CN110613691A (zh) * | 2018-06-19 | 2019-12-27 | 北京万全德众医药生物技术有限公司 | 一种含有peg-dspe-盐酸美金刚复合物的口崩片 |
| TWI826474B (zh) * | 2018-06-27 | 2023-12-21 | 日商第一三共股份有限公司 | 包含二胺衍生物之顆粒劑、以及其用途及製造方法 |
| CN109512790A (zh) * | 2018-12-28 | 2019-03-26 | 金日制药（中国）有限公司 | 一种口腔崩解片的处方及制备工艺 |
| WO2021095092A1 (ja) * | 2019-11-11 | 2021-05-20 | 大塚製薬株式会社 | 口腔内崩壊錠 |
| WO2022004871A1 (ja) * | 2020-07-03 | 2022-01-06 | あゆみ製薬株式会社 | 錠剤およびその製造方法 |
| WO2022024979A1 (ja) * | 2020-07-27 | 2022-02-03 | 第一三共株式会社 | ミロガバリンベシル酸塩を含有する口腔内崩壊錠 |
| JPWO2022102457A1 (xx) * | 2020-11-10 | 2022-05-19 | ||
| CN113181125B (zh) * | 2021-04-27 | 2022-07-19 | 海南通用三洋药业有限公司 | 一种西他沙星片剂及其制备方法 |
| CN113332252A (zh) * | 2021-06-07 | 2021-09-03 | 大桐制药（中国）有限责任公司 | 一种洛索洛芬钠片的制备方法 |
| CN113244238B (zh) * | 2021-06-16 | 2022-05-20 | 北京斯利安药业有限公司 | 含盐酸苯海索和叶酸的口崩片及其制备方法 |
| JP7210794B2 (ja) * | 2021-06-16 | 2023-01-23 | 日本ジェネリック株式会社 | リナグリプチン含有製剤及びリナグリプチン含有口腔内崩壊性錠剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0745382B1 (en) * | 1994-01-31 | 2003-11-12 | Yamanouchi Pharmaceutical Co. Ltd. | Intraorally soluble compressed molding and process for producing the same |
| JP4438121B2 (ja) | 1998-04-27 | 2010-03-24 | 大正製薬株式会社 | 口腔内速崩錠及びその製造方法 |
| JP2000273039A (ja) | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | 口腔内崩壊性組成物 |
| JP4551627B2 (ja) * | 2003-02-28 | 2010-09-29 | 東和薬品株式会社 | 口腔内崩壊錠剤の製造方法 |
| JP5584509B2 (ja) | 2003-02-28 | 2014-09-03 | 東和薬品株式会社 | 口腔内崩壊錠剤 |
| KR20060033727A (ko) | 2003-06-16 | 2006-04-19 | 알러간, 인코포레이티드 | 메만틴 경구 투여 제형 |
| JP3841804B2 (ja) | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| KR101400064B1 (ko) | 2006-04-13 | 2014-05-27 | 니폰 조키 세야쿠 가부시키가이샤 | 건식 직타 속붕괴성 정제 |
| CA2658549A1 (en) | 2006-08-08 | 2008-02-14 | Kissei Pharmaceutical Co., Ltd. | Oral disintegrating tablet having masked bitter taste and method for production thereof |
| WO2009102038A1 (ja) | 2008-02-13 | 2009-08-20 | Dainippon Sumitomo Pharma Co., Ltd. | 口腔内崩壊錠 |
| JP2010070466A (ja) | 2008-09-16 | 2010-04-02 | Kyoto Pharmaceutical Industries Ltd | 口腔内崩壊錠 |
| JP5549443B2 (ja) | 2009-07-15 | 2014-07-16 | ライオン株式会社 | 口腔内崩壊錠及びその製造方法 |
| EP2561892B1 (en) * | 2010-03-31 | 2015-05-06 | Mochida Pharmaceutical Co., Ltd. | Easily dosable solid preparation |
| JP5680898B2 (ja) | 2010-08-10 | 2015-03-04 | 京都薬品工業株式会社 | 苦味を抑制した速崩壊錠 |
| US9744134B2 (en) * | 2012-02-03 | 2017-08-29 | Asahi Kasei Chemicals Corporation | Orally disintegrating tablet containing bitterness-masking granules |
-
2013
- 2013-04-23 CN CN201710256576.8A patent/CN106913553A/zh active Pending
- 2013-04-23 CN CN201380021692.1A patent/CN104244930A/zh active Pending
- 2013-04-23 IN IN2029MUN2014 patent/IN2014MN02029A/en unknown
- 2013-04-23 JP JP2014512615A patent/JP6066351B2/ja active Active
- 2013-04-23 ES ES13781585.8T patent/ES2694224T3/es active Active
- 2013-04-23 KR KR1020147028967A patent/KR101943686B1/ko active IP Right Grant
- 2013-04-23 US US14/395,428 patent/US9827200B2/en active Active
- 2013-04-23 WO PCT/JP2013/061936 patent/WO2013161823A1/ja active Application Filing
- 2013-04-23 EP EP13781585.8A patent/EP2842549B1/en active Active
- 2013-04-23 BR BR112014026292-6A patent/BR112014026292B1/pt active IP Right Grant
- 2013-04-23 CA CA2870868A patent/CA2870868C/en active Active
- 2013-04-24 TW TW102114513A patent/TWI572371B/zh active
-
2015
- 2015-08-07 HK HK15107618.0A patent/HK1206983A1/xx unknown
-
2016
- 2016-10-17 JP JP2016203530A patent/JP6325627B2/ja active Active
-
2018
- 2018-01-22 JP JP2018008108A patent/JP6545839B2/ja active Active
-
2019
- 2019-06-19 JP JP2019113467A patent/JP7028829B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2842549A4 (en) | 2015-09-23 |
| TWI572371B (zh) | 2017-03-01 |
| JP6545839B2 (ja) | 2019-07-17 |
| WO2013161823A1 (ja) | 2013-10-31 |
| ES2694224T3 (es) | 2018-12-19 |
| CN104244930A (zh) | 2014-12-24 |
| BR112014026292B1 (pt) | 2022-09-27 |
| EP2842549B1 (en) | 2018-08-08 |
| JP2017008112A (ja) | 2017-01-12 |
| JP2019151670A (ja) | 2019-09-12 |
| IN2014MN02029A (xx) | 2015-08-14 |
| JP2018058910A (ja) | 2018-04-12 |
| US20150110880A1 (en) | 2015-04-23 |
| TW201347792A (zh) | 2013-12-01 |
| CA2870868C (en) | 2018-02-20 |
| CA2870868A1 (en) | 2013-10-31 |
| JP6325627B2 (ja) | 2018-05-16 |
| CN106913553A (zh) | 2017-07-04 |
| JPWO2013161823A1 (ja) | 2015-12-24 |
| US9827200B2 (en) | 2017-11-28 |
| EP2842549A1 (en) | 2015-03-04 |
| KR20150003740A (ko) | 2015-01-09 |
| JP6066351B2 (ja) | 2017-01-25 |
| BR112014026292A2 (pt) | 2017-06-27 |
| KR101943686B1 (ko) | 2019-01-29 |
| JP7028829B2 (ja) | 2022-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1206983A1 (en) | Orally disintegrating tablet and method for producing same | |
| EP2857401A4 (en) | Novel lactamase inhibitor and method for the preparation thereof | |
| ZA201304617B (en) | Orally disintegrating tablet | |
| EP2770079A4 (en) | STEEL SHEET AND METHOD FOR PRODUCING THE SAME | |
| GB2503355B (en) | Inserts and method for making same | |
| EP2797587A4 (en) | VERY ROBUST CRUSHING TABLET AND METHOD OF MANUFACTURING THEM | |
| EP2832350A4 (en) | PROCESS FOR PRODUCING DELIBERATE PARTICLE COMPOSITION COMPRISING ACIDIC TYPE CARBOXYMETHYLCELLULOSE, COMPOSITION OF DELITING PARTICLES COMPRISING ACIDIC TYPE CARBOXYMETHYLCELLULOSE, AND ORAL DISSOLUTION COMPRESSING CONTAINING DELIBERATIVE PARTICLE COMPOSITION COMPRISING CARBOXYMETHYLCELLULOSE OF ACID TYPE | |
| ZA201304366B (en) | Orally disintegrating tablet | |
| EP2913179A4 (en) | CYLINDRICAL CASING AND METHOD FOR PRODUCING CYLINDRICAL CASING | |
| GB2509677B (en) | Method for producing medical oversleeves and production system | |
| EP2905786A4 (en) | SCINTILLATE PANEL AND METHOD FOR PRODUCING A SCINTILLATE PANEL | |
| EP2933034A4 (en) | PRESSURE FORMING METHOD | |
| EP2934412A4 (en) | LAMINATE AND METHOD FOR THE MANUFACTURE THEREOF | |
| EP2857001A4 (en) | PROCESS FOR MANUFACTURING TABLET AND TABLET | |
| RS56562B1 (sr) | Postupak za proizvodnju belog lima i proizvod proizveden njime | |
| EP2924691A4 (en) | SCINTILLATE PANEL AND METHOD FOR PRODUCING A SCINTILLATE PANEL | |
| EP2743365A4 (en) | STEEL SHEET AND METHOD FOR PRODUCING THE SAME | |
| SG10201604976RA (en) | Hydroxy-aminopolymers and method for producing same | |
| EP2927368A4 (en) | FILM-LIKE OBJECT AND METHOD FOR PRODUCING THE FOLLOWED OBJECT | |
| ZA201400326B (en) | Bouillon tablet process | |
| SG11201504404SA (en) | Ring and process for producing the same | |
| EP2848619A4 (en) | PROCESS FOR PRODUCTION OF SEPI PATERINE AND TETRAHYDROLACTOYLPTERINE | |
| EP2844382A4 (en) | PARTICLES AND METHOD FOR PRODUCING PARTICLES | |
| EP2832540A4 (en) | MULTILAYER STRUCTURE AND METHOD FOR THE MANUFACTURE THEREOF | |
| EP2543502A4 (en) | METHOD FOR PRODUCING TABLETS |